Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$4.6M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$254M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Ryan Michelle R | Nov 11, 2024 | Sell | 2,800 | $59.7 | $170,000 |
| Ferraro Joseph Anthony | Oct 18, 2024 | Sell | 320 | $59.97 | $19,000 |
| McErlane David | Sep 26, 2024 | Sell | 1,994 | $59.97 | $120,000 |
| Evoli Lisa | Aug 2, 2024 | Sell | 3,859 | $59.67 | $230,000 |
| Gennadios Aristippos | Aug 2, 2024 | Sell | 1,169 | $59.55 | $70,000 |
| Hopson Ricky | Aug 2, 2024 | Sell | 662 | $59.56 | $39,000 |
| Gunther Scott | Aug 2, 2024 | Sell | 666 | $59.55 | $40,000 |
| Ferraro Joseph Anthony | Aug 2, 2024 | Sell | 608 | $59.58 | $36,000 |
| Maselli Alessandro | Jul 29, 2024 | Sell | 9,088 | $58.76 | $530,000 |
| Hopson Ricky | Jul 29, 2024 | Sell | 206 | $58.67 | $12,000 |
| Gunther Scott | Jul 29, 2024 | Sell | 283 | $58.69 | $17,000 |
| Gennadios Aristippos | Jul 29, 2024 | Sell | 349 | $58.7 | $20,000 |
| Masanovich Matti | Jul 8, 2024 | Sell | 2,993 | $56.74 | $170,000 |
| Hopson Ricky | Jun 4, 2024 | Sell | 1,401 | $54.2631 | $76,000 |
| Gunther Scott | Mar 15, 2024 | Sell | 387 | $56.2 | $22,000 |
| Ryan Michelle R | Aug 31, 2023 | Buy | 1,000 | $49.98 | $50,000 |
| GREISCH JOHN J | Aug 30, 2023 | Buy | 21,000 | $50.24 | $1.1M |
| Maselli Alessandro | Aug 24, 2023 | Sell | 1,970 | $44.51 | $88,000 |
| Maselli Alessandro | Aug 24, 2023 | Sell | 101 | $45.15 | $4,600 |
| Gunther Scott | Aug 24, 2023 | Sell | 269 | $44.57 | $12,000 |
| Grippo Michael J | Aug 24, 2023 | Sell | 390 | $44.5 | $17,000 |
| Gennadios Aristippos | Aug 24, 2023 | Sell | 396 | $44.49 | $18,000 |
| Fasman Steven L | Aug 24, 2023 | Sell | 817 | $44.65 | $36,000 |
| Carletti Lorenzo | Aug 24, 2023 | Sell | 216 | $44.71 | $9,700 |
| Hopson Ricky | Aug 24, 2023 | Sell | 276 | $44.56 | $12,000 |
| Hawkeswood Thomas W | Aug 24, 2023 | Sell | 147 | $44.72 | $6,600 |
| Lickfold Charles | Aug 24, 2023 | Sell | 190 | $44.72 | $8,500 |
| Hunt Patricia | Aug 24, 2023 | Sell | 106 | $44.77 | $4,700 |
| Pravda Ricardo | Aug 24, 2023 | Sell | 379 | $44.47 | $17,000 |
| Arnold Jonathan | Aug 24, 2023 | Sell | 87 | $44.87 | $3,900 |
| Fasman Steven L | Aug 1, 2023 | Sell | 1,113 | $46.72 | $52,000 |
| Pravda Ricardo | Aug 1, 2023 | Sell | 222 | $47.78 | $11,000 |
| Maselli Alessandro | Aug 1, 2023 | Sell | 879 | $46.71 | $41,000 |
| Maselli Alessandro | Aug 1, 2023 | Sell | 606 | $47.75 | $29,000 |
| Lickfold Charles | Aug 1, 2023 | Sell | 135 | $47.9 | $6,500 |
| Hunt Patricia | Aug 1, 2023 | Sell | 161 | $47.95 | $7,700 |
| Hopson Ricky | Aug 1, 2023 | Sell | 195 | $47.86 | $9,300 |
| Hawkeswood Thomas W | Aug 1, 2023 | Sell | 258 | $47.97 | $12,000 |
| Gunther Scott | Aug 1, 2023 | Sell | 190 | $47.9 | $9,100 |
| Grippo Michael J | Aug 1, 2023 | Sell | 241 | $47.88 | $12,000 |
| Gennadios Aristippos | Aug 1, 2023 | Sell | 220 | $47.87 | $11,000 |
| Carletti Lorenzo | Aug 1, 2023 | Sell | 383 | $47.77 | $18,000 |
| Fasman Steven L | Aug 1, 2023 | Sell | 524 | $47.76 | $25,000 |
| Pravda Ricardo | Aug 1, 2023 | Sell | 47 | $46.5 | $2,200 |
| Grippo Michael J | Aug 1, 2023 | Sell | 35 | $46.64 | $1,600 |
| Gennadios Aristippos | Aug 1, 2023 | Sell | 61 | $46.58 | $2,800 |
| Arnold Jonathan | Aug 1, 2023 | Sell | 62 | $47.8 | $3,000 |
| Boerman Manja | May 1, 2023 | Sell | 1,446 | $49.86 | $72,000 |
| Gargiulo Mario | May 1, 2023 | Sell | 678 | $49.86 | $34,000 |
| Hopson Ricky | Jan 23, 2023 | Sell | 643 | $49.36 | $32,000 |
What's the latest insider transaction for Catalent?
The most recent insider transaction for Catalent was conducted by Ryan Michelle R, who sold 2,800 shares on November 11, 2024 at a price of $59.70 per share.
Which insider bought the most CTLT stock over the last two years?
GREISCH JOHN J has bought the most CTLT stock in the last 2 years, with a total value of $1.1M.
Which insider has sold the most CTLT stock over the last two years?
Maselli Alessandro has sold the most CTLT stock in the last 2 years, with a total value of $700,000.
What is the total value of insider transactions for Catalent (CTLT) in the last 2 years?
The total value of insider transactions for Catalent in the last 2 years is negative, amounting to -$1.1M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Catalent's market confidence?
Over the last 2 years, insider transactions for Catalent have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
